Page last updated: 2024-09-05

tolvaptan and Cell Transformation, Neoplastic

tolvaptan has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koch, M; Schulz, C; Utpatel, K	1

Other Studies

1 other study(ies) available for tolvaptan and Cell Transformation, Neoplastic

Article	Year
[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma]. Der Internist, 2018, Volume: 59, Issue:4 Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors	2018

Article

Year

[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma].

Der Internist, 2018, Volume: 59, Issue:4

Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors

2018